...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

I would like to know from Josh if he sold any ZHCLF. Is it easier buying in than selling out?

(Stock liquidity?)

 

Koo

Share
New Message
Please login to post a reply